Skip to main content
Clinical Trials/JPRN-UMIN000012874
JPRN-UMIN000012874
Recruiting
未知

Prospective multicenter clinical study on outcome measures for HTLV-1-associated myelopathy (HAM) - HAM-OM

St. Marianna University0 sites150 target enrollmentJanuary 16, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
St. Marianna University
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2014
End Date
January 13, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
St. Marianna University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with spinal cord compression lesion complications such as from cervical spine disease,intervertebral disc herniation, or yellow ligament ossification that affect gait assessment 2\. Patients with knee or hip osteoarthritis, rheumatoid arthritis, or another musculoskeletal disease that affects gait assessment 3\. Patients with Parkinsons disease or the aftereffects of stroke, cerebral hemorrhage, subarachnoid hemorrhage or other neurological disturbance affecting gait assessment 4\. Serious complications that affect gait assessment (heart failure, respiratory dysfunction, renal failure, liver failure, etc.) 5\. Patients with mental disorders such as dementia or neuropsychiatric diseases that affect ability to answer interview questions 6\. Patients with any disease other than HAM for which they might be prescribed steroids (excluding topic medicines), interferon, or anti\-cancer drugs 7\. Patients with both severe anemia (hemoglobin less than 9\.0 g/dl) and intracranial hypotension syndrome from whom it is deemed unwise with regard to the subjects safety to collect blood or CSF samples 8\. Patients who have been deemed unfit for the study by a study investigator or physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials